Skip to main content
. 2017 Nov 9;7:15210. doi: 10.1038/s41598-017-13121-9

Figure 2.

Figure 2

Changes in subjective symptoms in diquafosol and rebamipide groups assessed by the Dry Eye-Related Quality of Life Scores: (a) changes in the total score, (b) changes in the ophthalmic symptoms, and (c) changes in the quality of life-related scores.